FCX News Alert Freeport-Mcmoran Inc. (FCX) 20.29 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Freeport-Mcmoran Inc. (FCX) 20.29 $FCX

6 Top S&P 500 Dividend Dogs Tail 13% To 33% February Upsides
Fredrik Arnold - at Seeking Alpha - 1 hr 8 mins ago

KMI: 41.97 (+0.21), FTR: 8.38 (+0.01), HCP: 42.87 (+0.20), OKE: 47.32 (+0.04), FCX: 20.29 (+0.82), COP: 69.88 (+1.84), CNP: 21.76 (-0.35), WIN: 8.94 (+0.06), T: 34.66 (+0.05), RIG: 19.05 (+0.42), ESV: 30.03 (+0.41), MAT: 27.61 (+0.17), PPL: 34.69 (-0.16), WMB: 49.41 (+1.44), CTL: 39.46 (+0.17), NE: 18.54 (+0.30)

Watch for Freeport-McMoRan to Potentially Pullback After Gaining 4.21% Yesterday
Comtex SmarTrend(R) - Fri Feb 13, 3:47PM CST
Freeport-McMoRan (NYSE:FCX) traded in a range yesterday that spanned from a low of $19.76 to a high of $20.50. Yesterday, the shares gained 4.2%, which took the trading range above the 3-day high of $19.57 on volume of 19.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
FCX: 20.29 (+0.82)

After Yesterday's Rally of 4.21% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri Feb 13, 3:46PM CST
Freeport-McMoRan (NYSE:FCX) traded in a range yesterday that spanned from a low of $19.76 to a high of $20.50. Yesterday, the shares gained 4.2%, which took the trading range above the 3-day high of $19.57 on volume of 19.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
FCX: 20.29 (+0.82)

Enough of Greece -- Investors to Refocus on U.S. Economy Next Week
at The Street - Fri Feb 13, 3:05PM CST
Greece demanded focus this week as eurozone power dynamics tugged the strings of stock markets.
D: 72.91 (-0.81), AXP: 78.08 (-2.40), DUK: 79.84 (-1.22), EXC: 33.51 (-0.93), FCX: 20.29 (+0.82), VFC: 75.26 (+4.26), XLU: 45.17 (-0.70), SO: 45.88 (-0.68), VLO: 58.60 (+2.05), MPC: 103.48 (+2.08), BHP: 51.19 (+2.38), COST: 147.10 (-0.66), AIG: 53.96 (+1.51), RIO: 49.37 (+2.22), XLE: 82.04 (+1.70), CBS: 59.83 (+2.06)

Stock Markets Recover Gains as Energy Rally Charges Ahead
at The Street - Fri Feb 13, 2:14PM CST
U.S. stocks pare gains mid-afternoon Friday as a selloff in utilities overshadows a boost to energy stocks.
D: 72.91 (-0.81), DUK: 79.84 (-1.22), CAG: 34.83 (-1.59), FCX: 20.29 (+0.82), XOM: 93.37 (+1.00), VLO: 58.60 (+2.05), BHP: 51.19 (+2.38), CAT: 85.13 (+1.60), GRPN: 7.97 (+0.51), RIO: 49.37 (+2.22), ZNGA: 2.24 (-0.42), KING: 16.70 (+1.96), XLE: 82.04 (+1.70), AXP: 78.08 (-2.40), EXC: 33.51 (-0.93), VFC: 75.26 (+4.26), XLU: 45.17 (-0.70), SO: 45.88 (-0.68), MPC: 103.48 (+2.08), AIG: 53.96 (+1.51), FSL: 37.53 (+2.83), CVX: 112.78 (+1.92), CBS: 59.83 (+2.06)

Dow Pops Above 18,000 as Oil Stocks Provide Energy Boost
at The Street - Fri Feb 13, 10:06AM CST
The Dow regains the 18,000 level on Friday, getting a boost from oil- and industry-related components.
CAG: 34.83 (-1.59), FCX: 20.29 (+0.82), XOM: 93.37 (+1.00), VLO: 58.60 (+2.05), MPC: 103.48 (+2.08), BHP: 51.19 (+2.38), AIG: 53.96 (+1.51), ZNGA: 2.24 (-0.42), FSL: 37.53 (+2.83), GRPN: 7.97 (+0.51), RIO: 49.37 (+2.22), CBS: 59.83 (+2.06), KING: 16.70 (+1.96), XLE: 82.04 (+1.70)

The 10 Most Overpaid CEOs Running Multi-Billion Dollar Companies
at The Street - Fri Feb 13, 8:22AM CST
Which CEOs have the most egregious pay packages?
VIA: 69.08 (+1.02), MCK: 224.89 (+0.12), NBR: 12.73 (+0.52), FCX: 20.29 (+0.82), DISCA: 31.45 (+1.11), DIS: 104.17 (+0.59), CVS: 102.63 (-0.37), REGN: 402.40 (+0.66), ORCL: 43.93 (+0.04), CBS: 59.83 (+2.06)

Post-Earnings Research - Freeport-McMoRan
PR Newswire - Fri Feb 13, 8:15AM CST
Editor Note: For more information about this release, please scroll to bottom.
FCX: 20.29 (+0.82)

Rio Tinto has no major acquisition plans, CEO says
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 10:59AM CST

FCX: 20.29 (+0.82), RIO: 49.37 (+2.22)

Shares of FCX Down 28.6% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Feb 12, 9:16AM CST
SmarTrend identified a Downtrend for Freeport-McMoRan (NYSE:FCX) on November 28th, 2014 at $27.01. In approximately 3 months, Freeport-McMoRan has returned 28.58% as of today's recent price of $19.29.
FCX: 20.29 (+0.82)

Freeport McMoRan - Well-Positioned For Future Growth
William M. Thomson - at Seeking Alpha - Wed Feb 11, 12:33PM CST

FCX: 20.29 (+0.82)

Watch for Shares of Freeport-McMoRan (FCX) to Approach Support at $18.04
Comtex SmarTrend(R) - Wed Feb 11, 12:25PM CST
Freeport-McMoRan (NYSE:FCX) has opened bearishly below the pivot of $18.82 today and has reached the first level of support at $18.37. Investors may be interested in a cross of the next downside pivot targets of $18.04 and $17.26.
FCX: 20.29 (+0.82)

Mining: In Simplicity Lies Investment Success
Ted Waller - at Seeking Alpha - Wed Feb 11, 11:13AM CST

ZINC: 13.95 (+0.26), DBB: 15.26 (unch), BTU: 7.65 (+0.46), VALE: 8.05 (+0.32), BHP: 51.19 (+2.38), FCX: 20.29 (+0.82), COPX: 7.00 (+0.25), KOL: 14.24 (+0.27), XME: 29.95 (+0.63), RIO: 49.37 (+2.22)

Freeport-McMoRan Rises 3.50% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Feb 09, 3:56PM CST
Freeport-McMoRan (NYSE:FCX) traded in a range yesterday that spanned from a low of $18.85 to a high of $19.78. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $19.62 on volume of 19.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
FCX: 20.29 (+0.82)

Earnings Forecast Research for Alibaba, Frontier, Akamai Technologies, Gilead Sciences, Halliburton, and Freeport-McMoRan
PR Newswire - Mon Feb 09, 7:45AM CST
EarningForecast.com has issued earnings forecast research with special focus on financial performance of the following stocks: Alibaba (NYSE:BABA), Frontier (NASDAQ:FTR), Akamai Technologies (NASDAQ:AKAM), Gilead Sciences (NASDAQ:GILD), Halliburton (NYSE:HAL), and Freeport-McMoRan (NYSE:FCX).
FTR: 8.38 (+0.01), GILD: 101.90 (+1.10), AKAM: 68.77 (+1.18), FCX: 20.29 (+0.82), HAL: 44.19 (+1.42), BABA: 89.05 (+1.95)

FREEPORT-MCMORAN (FCX) NOTE HOLDER INVESTIGATION - Andrews & Springer LLC Announces Investigation of Freeport-McMoRan Inc.
Business Wire - Mon Feb 09, 7:03AM CST
Andrews & Springer LLC, a boutique securities class action law firm focused on representing investors nationwide, is investigating potential securities fraud claims against Freeport-McMoRan Inc. (NYSE:FCX) ("FCX" or the "Company" in connection with the Company's November 14, 2014, Notes Offering.
FCX: 20.29 (+0.82)

Freeport-McMoRan (FCX) Stock Lower Today as Copper Prices Decline
at The Street - Fri Feb 06, 2:13PM CST
Shares of Freeport-McMoRan (FCX) are down in afternoon trading as copper prices declined today.
FCX: 20.29 (+0.82)

Stock Market News for February 06, 2015 - Market News
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 9:10AM CST
Rise in oil prices, new deals and upbeat quarterly results helped benchmarks settle in the green on Thursday
KMI: 41.97 (+0.21), BIIB: 391.66 (-0.45), VRTX: 113.66 (+4.03), MON: 124.77 (+2.00), FCX: 20.29 (+0.82), PFE: 34.64 (-0.23), AMGN: 153.48 (+0.30), XOM: 93.37 (+1.00), COP: 69.88 (+1.84), SLB: 88.38 (+2.42), HSP: 87.35 (unch), AA: 15.81 (+0.16), EOG: 96.92 (+2.12), CVX: 112.78 (+1.92), DOW: 49.44 (+0.29)

Digging For Dividends In Precious Metals
Wall Street Daily - Seeking Alpha - Fri Feb 06, 6:04AM CST
By Martin Hutchinson Today, it can be difficult to find a precious metals stock that provides a reliable, worthwhile dividend. And since gold and other precious metals don't pay dividends directly, income investors are hard-pressed to attain a...
ABX: 12.14 (+0.01), HL: 3.42 (+0.05), FCX: 20.29 (+0.82), AGI: 5.78 (+0.03), NSU: 3.73 (+0.13)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Hims & Hers Health Faces Revenue Challenges and Legal Issues

Updated Category News Views 246

Hims & Hers Revenue Challenges Amid Stock Decline In recent trading sessions, Hims & Hers Health reported notable stock fluctuations as the company unveiled a decline in revenue per customer linked to its customization of GLP-1 medications for weight loss. This announcement caused an almost 11% drop in the stock price. Impacts of Collaboration Termination This steep...

Continue Reading
Entrée Resources Reports Solid Results for Q3 2025

Updated Category News Views 166

Entrée Resources Ltd. Overview Entrée Resources Ltd. (TSX: ETG; OTCQB: ERLFF), a reputable Canadian mining company focused on the Oyu Tolgoi project, has announced its interim financial results for the third quarter of 2025. This announcement sheds light on its ongoing operations and future plans, emphasizing the company's significant role in one of the world's largest...

Continue Reading
Bucket List Wine Dinners Beckon to Los Angeles

Updated Category News Views 10

Sipping on the Extraordinary: LA Wine Soiree When was the last time you had a glass of wine that truly feels like you've unlocked a treasure chest? That's what LearnAboutWine.com is going for with their bucket list wine dinners in Los Angeles. Imagine tasting some of the world's most coveted bottles, all served with a level of polish that screams high-end dining. Led by...

Continue Reading
BioLife Solutions Enhances Growth Potential with $73 Million Sale

Updated Category News Views 68

BioLife Solutions Announces $73 Million Sale of SciSafe In a significant move aimed at reinforcing its strategic direction, BioLife Solutions, Inc. (NASDAQ: BLFS), a prominent player in the development and supply of cell processing tools and services for the cell and gene therapy market, has announced the sale of its biostorage subsidiary, SciSafe Holdings, Inc. The...

Continue Reading
Advancements in Universal Vaccine Development by Dx&Vx

Updated Category News Views 154

Innovative Pathway Towards a Universal COVID-19 Vaccine In the wake of a global resurgence of COVID-19, Dx&Vx (DXVX) is stepping up its efforts to develop a universal vaccine aimed at providing protection against all variants of the virus. With the recent acquisition of cutting-edge technology, this next-generation vaccine is set to attract significant global interest....

Continue Reading